A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. - Wikidata - awgldk - TriplyDB

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

http://www.wikidata.org/entity/Q51721153

about

Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer Epidermal growth factor receptor tyrosine kinase defines critical prognostic genes of stage I lung adenocarcinoma The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.Prognostic factors in resected lung carcinomas.Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis Proposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease.UHRF1 is a novel diagnostic marker of lung cancer.Prognostic value of CD133 expression in stage I lung adenocarcinomas.The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer.Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients.Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.Completeness of TNM staging of small-cell and non-small-cell lung cancer in the Danish cancer registry, 2004-2009 Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance Changes in the demographics and prognoses of patients with resected non-small cell lung cancer: a 20-year experience at a single institution in Korea.Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis.Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.Elevated microsatellite alterations at selected tetra-nucleotide (EMAST) in non-small cell lung cancers--a potential determinant of susceptibility to multiple malignancies Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.Validation of EBUS-TBNA-integrated nodal staging in potentially node-positive non-small cell lung cancer.Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report.

P2860

Q28080636-9ECBA6BF-DBAB-4A1E-AFE4-2BF9E5A9359B Q28388842-FD1CFDAF-F748-4950-BA4A-F225BC28439E Q33613697-0D050F88-1B86-44E4-96FC-AFE14B43B4A2 Q33697964-E788F7F5-5CB8-414A-A127-F8630C068E08 Q33777586-85FBC5A4-00D7-4C11-ABB4-B48FCFF89B02 Q33780321-0A7F508C-5EB0-4933-A55B-321D0012BF45 Q33861078-765744E9-0123-4EB3-94B0-68F3155AF2A1 Q34005854-68CB5E10-101B-4DBD-9610-A6F8BE7263A7 Q34467221-77D55C43-AAAF-4B37-B65B-613B407AE39D Q34587180-09795694-597F-4FA2-AF5C-72455179B81F Q34627201-15FF159E-88B0-4F93-843C-E8BE73D27779 Q34752733-2A6DDCFD-8085-42EF-B8F7-865D04EB5CF7 Q35096604-AF40B682-1D04-4DED-9E7B-ED3417C0947D Q35663412-594DED84-EBF3-45BB-9E3D-5B0556F05615 Q35869109-3B5EB265-C648-41DF-9238-3CA5C00F547A Q35993714-CEB752E8-355D-4A74-8E31-DD8936AF126B Q36051720-53419412-470E-4ABE-A343-23E751DCBE09 Q36151953-1C7B43E0-71E1-4605-8D96-9489D89298CC Q36194013-BD40BE6A-2984-4552-8C01-44A865925635 Q36195038-D1918AC7-281D-42E5-824A-E8A8A1D6CCDA Q36257504-1FBA21FA-BB9F-4E6D-AFFC-08A7BFCF9F6F Q36326386-34C8D0FF-464F-445F-98AE-EED8856041BD Q36449835-7C2D3A29-BB85-4105-8FF3-C7E901637E62 Q36472952-0E5DB3AB-C1CB-4821-81A5-C2287C09E08E Q36474910-D2A6604E-F2DA-4DB8-9FC4-FE122A8B420A Q36514569-DC9E52D6-754B-476C-B689-ADAD697ACA73 Q36524133-55EB82AE-FFB9-4FF8-BDCE-D6666C7CEAEC Q36543892-3DA97339-CD48-4656-8A63-A90609620148 Q36584314-CD516754-DE7A-4953-B55F-38F5465153EA Q36617872-4BC7EBDB-3200-46D9-9ECB-ADFD99BC086C Q36656090-204973A4-ABFC-42C2-926A-0E49428A73D7 Q36734816-0CAB27D6-BA13-4F8C-9D65-8ED04FC655D4 Q36750995-8BC961E2-5C45-495C-9898-01C277C674B6 Q36793866-BA551C66-DAA8-4FFE-8800-B9C61E9BE1CD Q36951322-8884080F-B462-4446-BD45-B3C626527722 Q37121482-9DDBAA06-3952-45BB-B1D7-55846387BAFE Q37147498-F22EECFA-6623-44B6-B7D6-1BD9B60601BC Q37171930-B9EA38CC-CCDF-4BE3-9F28-594246C3899B Q37567804-D9E01D67-00CF-4C81-A78A-432624C9B151 Q37656881-A1976585-5318-4653-B1AB-63D4F94B923B

P2860

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

http://www.wikidata.org/entity/Q51721153

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@en

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@nl

type

label

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@en

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@nl

prefLabel

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@en

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@nl

P1433

Q51721153-F348EB82-D382-4566-B520-12014231049D

P1476

Q51721153-89F97B1C-626B-4DE4-84E1-D3CABA13604A

P2093

Q51721153-199DD3D0-1BDC-4592-9B5F-92D410E43BE1

Q51721153-1CEBAC9B-9D86-4B29-84D1-3733EACF89B3

Q51721153-33196E37-58C8-4305-9C94-307F988BFDC5

Q51721153-38A213D1-392E-4ED2-BBC4-346BCC226132

Q51721153-460DD3D7-81B4-4ADB-A557-FB4B27A41DB3

Q51721153-4DD8B7C9-30DE-4846-8669-BCF483685620

Q51721153-5C13B9B5-E2A6-4017-B29B-BE08850DD493

Q51721153-5C9BB631-C62E-4673-B500-424DC4D9684E

Q51721153-969689A5-7D98-40C3-B549-71C4E1F6952B

Q51721153-A703394B-AB66-410B-8F08-0B0DA731F4D2

P304

Q51721153-E651D7AC-5ADF-4391-8BBD-C47475B6D9AB

P31

Q51721153-DD23F7D1-1221-4017-9BFB-63F3E2BD68C3

P356

Q51721153-66FBCF57-58A0-4E30-917E-A6D635978FD9

P433

Q51721153-329BFA67-B661-4526-8F39-3A8CF999D037

P478

Q51721153-01E89AC0-3F09-4EDA-8AA2-8B942BD70AD1

P577

Q51721153-4A34A476-0E1F-4F4D-9053-8D9646A4DB6A

P698

Q51721153-97A452EC-7EFB-4E82-8284-BF9793DA410E

P356

JTO.0B013E31815E8577

P1433

Journal of Thoracic Oncology

P1476

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

@en

P2093

Etsuo Miyaoka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Inoue

http://www.w3.org/2001/XMLSchema#string

Hisao Asamura

http://www.w3.org/2001/XMLSchema#string

Japanese Joint Committee of Lung Cancer Registry

http://www.w3.org/2001/XMLSchema#string

Kaoru Shimokata

http://www.w3.org/2001/XMLSchema#string

Kenji Eguchi

http://www.w3.org/2001/XMLSchema#string

Masaki Mori

http://www.w3.org/2001/XMLSchema#string

Ryosuke Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Goya

http://www.w3.org/2001/XMLSchema#string

Toshihiro Nukiwa

http://www.w3.org/2001/XMLSchema#string

P304

46-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JTO.0B013E31815E8577

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18166840

http://www.w3.org/2001/XMLSchema#string